GLP-1 agonist drugs like Ozempic, and SLGT2 inhibitor drugs like Jardiance have been linked with a lower risk of a second ...

As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...

Ozempic, a popular weight-loss drug, has helped many shed pounds and improve their health. However, discontinuing the ...

Four out of five men and women in the United States will be overweight or obese by 2050 if current trends hold, a new study ...

The use of weight loss drugs without doctor's supervision is not advisable and can lead to serious side effects and ...

GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply ...

Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

The company's revenue jumped 77% in Q3 to reach $401.6 million in Q3 2024, alongside a net income of $75.6 million. It now ...

A new study supports the notion that the same mechanisms that help folks lose weight with Ozempic and its kin also work to ...

Polen Capital, an investment management company, released its “Polen Global Growth Strategy” third-quarter 2024 investor ...

We narrow down the most important market and consumer trends that could influence dairy product innovation in 2025.